To read this full article you need to be subscribed to Newsline.
Sign in Sign up for a FREE subscriptionPandemic stokes already robust demand for real estate in life sciences sector
The pandemic has accelerated momentum in the U.S. life sciences industry, particularly amid the race to produce a COVID-19 vaccine and develop other medicines for human ailments. The sector, which has reached new highs this year in R&D employment and venture-capital funding, is seeing a surge in demand for life sciences real estate in markets from longstanding centers like Boston to emerging hubs such as Pittsburgh, according to a new report from CBRE.